Skip to main content

Murphy Polly A.'s Form 4/A amendment

Amended

Atea Pharmaceuticals, Inc. (AVIR) · filed May 21, 2026

Accession no.
0001193125-26-235039
Filed
May 21, 2026
Trade date
May 18, 2026
Filing delay
3 days
Rule 10b5-1 plan
Not checked
Original filed
May 20, 2026

This filing lists 1 non-derivative transaction. Open-market purchases total $25.4K. It was filed 3 days after the trade.

This amendment replaces 0001193125-26-232612 (filed May 20, 2026).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Murphy Polly A.CIK 0001829248Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 18, 2026Common StockPPurchaseAcquired+6,100$4.17F2+$25,43792,145Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

This Form 4/A has been filed solely to correct the date of the transaction reported in Column 2 of Table I of the Reporting Person's Form 4 filed on May 20, 2026, which was inadvertently noted as "May 18, 2025" instead of "May 18, 2026."

F2

The price reported in Column 4 is a weighted average price. The securities were purchased in multiple transactions at prices ranging from $4.14 to $4.19 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)